Bromma, Sweden

Peter Kaufmann

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Moberg Pharma Ab. Active years: 2015-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Peter Kaufmann. Retrieved from https://idiyas.com/inventor/peter-kaufmann-laqxn83b

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2015-2017

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: **Innovative Solutions in Fungal Treatment: The Contributions of Peter Kaufmann**

Introduction

Peter Kaufmann, an esteemed inventor based in Bromma, Sweden, has made significant contributions in the field of pharmaceuticals, particularly focusing on treatments for fungal infections. With a remarkable portfolio consisting of two patents, Kaufmann has been instrumental in developing effective pharmaceutical compositions aimed at enhancing patient care.

Latest Patents

Among Kaufmann's notable inventions is a pharmaceutical composition designed for the treatment of onychomycosis, a common nail disease caused by fungal infections. This composition includes a urea-based component, a diol component such as propylene glycol, an organic acid component such as lactic acid, and a triol component like glycerol. Moreover, he has developed methods to improve the storage stability of these compositions, ensuring their effectiveness over time, which is vital for topical applications on the skin and nails.

Career Highlights

Peter Kaufmann currently works at Moberg Pharma AB, a company recognized for its commitment to innovation in the pharmaceutical sector. His work focuses on advancing treatments that are safe and effective for consumers, demonstrating his dedication to improving healthcare outcomes.

Collaborations

Kaufmann has had the privilege of collaborating with talented colleagues, including Ewa Karlsson and Sahar Feizollahi Ashkar. These collaborations have fostered a dynamic work environment, driving forward the development of groundbreaking therapeutic solutions.

Conclusion

With his innovative mindset and dedication to treating fungal infections, Peter Kaufmann continues to make a profound impact in the pharmaceutical industry. His patents not only highlight his creativity as an inventor but also emphasize the importance of developing reliable treatments for patients in need. Through his work at Moberg Pharma AB, Kaufmann exemplifies the potential for innovation to enhance healthcare solutions globally.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…